Roche Ready To File First-In-Class Eye Drug Despite Mixed Phase III Results

 
• By Andrew McConaghie
  
Close up cropped shot of woman's eye looking into the distance
(Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D